Clinical Trials Logo

Clinical Trial Summary

Radiotherapy of oral cavity cancer and sinonasal cancer is associated with acute and late morbidity. Use of an intraoral stent will provide a larger distance between the tongue and palate and can reduce side-effects. The aim of the present study is to confirm that an intraoral stent is not a significant bother to the patients.


Clinical Trial Description

The investigators have previously performed a pilot study on the feasibility of the intraoral stent in patients receiving radiotherapy for tongue cancer. It was found that most of the patients tolerated the stent. The mean radiation dose to the hard palate was reduced by 61% (absolute percentage) as compared with a control group not using the stent. Based on these results, the investigators wish to perform a study on a larger cohort to confirm that the intraoral stent will not lead to increased symptoms towards the end of the radiotherapy period. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04330781
Study type Interventional
Source Oslo University Hospital
Contact Einar Dale, MD PhD
Phone +4722934000
Email eindal@ous-hf.no
Status Recruiting
Phase Phase 2
Start date January 1, 2020
Completion date December 2025

See also
  Status Clinical Trial Phase
Completed NCT01695122 - Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 2
Recruiting NCT05793151 - Multi-Site Trial of Navigation vs Treatment as Usual for Delays in Starting Adjuvant Therapy N/A
Recruiting NCT01958762 - Screening for Cancers in the Oral CAvity N/A
Recruiting NCT05429099 - Mandibular Reconstruction Preplanning (ViPMR) Phase 2/Phase 3
Recruiting NCT05757817 - Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae N/A
Active, not recruiting NCT02586207 - Pembrolizumab in Combination With CRT for LA-SCCHN Phase 1
Recruiting NCT04809324 - Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers N/A
Recruiting NCT02012699 - Integrated Cancer Repository for Cancer Research
Terminated NCT03555721 - CytID Analysis of Oral Lesions
Completed NCT01116843 - Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment Phase 1/Phase 2
Recruiting NCT05375266 - Immune Biomarker Study for Head and Neck Cancer
Active, not recruiting NCT03082534 - Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma Phase 2
Completed NCT03096808 - Adaptive Radiotherapy for Head and Neck Cancer Phase 2
Completed NCT00359645 - Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population Phase 3
Completed NCT02412241 - Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients N/A
Terminated NCT00934739 - A Study of High-Risk Oral Cavity Cancer Phase 2/Phase 3
Not yet recruiting NCT06407570 - Dysphagia and Quality of Life in Patients With Oral Squamous Cell Carcinoma Before and After Treatment
Recruiting NCT05337631 - Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
Recruiting NCT05927220 - WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA
Recruiting NCT05369234 - Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis Phase 3